References
  1. Lehane E, McCarthy G. Intentional and unintentional medication non-adherence: A comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud . 2007;44(8):1468-1477. doi:10.1016/j.ijnurstu.2006.07.010
  2. Vrijens B, De Geest S, Hughes D et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol . 2012;73(5):691-705. doi:10.1111/j.1365-2125.2012.04167.x
  3. Sabaté E. Adherence To Long-Term Therapies: Evidence For Action . Geneva: World health organization; 2003.
  4. Brown M, Bussell J, Dutta S, Davis K, Strong S, Mathew S. Medication Adherence: Truth and Consequences. Am J Med Sci . 2016;351(4):387-399. doi:10.1016/j.amjms.2016.01.010
  1. Jafari Oori M, Mohammadi F, Norouzi-Tabrizi K, Fallahi-Khoshknab M, Ebadi A. Prevalence of medication adherence in patients with hypertension in Iran: A systematic review and meta-analysis of studies published in 2000-2018. ARYA Atheroscler . 2019;15(2):82‐92. doi:10.22122/arya.v15i2.1807
  2. Cheen M, Tan Y, Oh L, Wee H, Thumboo J. Prevalence of and factors associated with primary medication non‐adherence in chronic disease: A systematic review and meta‐analysis. Int J Clin Pract. 2019;73(6):e13350. doi:10.1111/ijcp.13350
  3. Mongkhon P, Kongkaew C. Medication Non-Adherence Identified at Home: A Systematic Review and Meta-analysis. Qual Prim Care . 2017;25(2):73-80.
  4. Uchmanowicz B, Jankowska E, Uchmanowicz I, Morisky D. Self-Reported Medication Adherence Measured With Morisky Medication Adherence Scales and Its Determinants in Hypertensive Patients Aged ≥60 Years: A Systematic Review and Meta-Analysis. Front Pharmacol . 2019;10. doi:10.3389/fphar.2019.00168
  5. Gebeyehu D, Mulat H, Bekana L et al. Psychotropic medication non-adherence among patients with severe mental disorder attending at Bahir Dar Felege Hiwote Referral hospital, north west Ethiopia, 2017. BMC Res Notes . 2019;12(1). doi:10.1186/s13104-019-4126-2
  6. World Health Organization (WHO). Mental disorders. Who.int. https://www.who.int/news-room/fact-sheets/detail/mental-disorders. Published 2018. Accessed November 13, 2019.
  7. Greenberg P, Fournier A, Sisitsky T, Pike C, Kessler R. The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010). J Clin Psychiatry . 2015;76(02):155-162. doi:10.4088/jcp.14m09298
  8. American Psychiatric Association (APA). Diagnostic And Statistical Manual Of Mental Disorders (DSM-5®) . 5th ed. Washington, D.C.: American Psychiatric Association; 2013.
  9. Bromet E, Andrade L, Hwang I et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med . 2011;9(1). doi:10.1186/1741-7015-9-90
  10. Ferrari A, Charlson F, Norman R et al. Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010. PLoS Med . 2013;10(11):e1001547. doi:10.1371/journal.pmed.1001547
  11. World Federation for Mental Health. DEPRESSION: A Global Crisis . Who.int: World Health Organization; 2012. https://www.who.int/mental_health/management/depression/wfmh_paper_depression_wmhd_2012.pdf. Accessed November 20, 2019.
  12. Ho S, Chong H, Chaiyakunapruk N, Tangiisuran B, Jacob S. Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: A systematic review. J Affect Disord . 2016;193:1-10. doi:10.1016/j.jad.2015.12.029
  13. Brijnath B, Antoniades J. “I’m running my depression:” Self-management of depression in neoliberal Australia. Soc Sci Med . 2016;152:1-8. doi:10.1016/j.socscimed.2016.01.022
  14. Lam W, Fresco P. Medication Adherence Measures: An Overview. Biomed Res Int . 2015;2015:1-12. doi:10.1155/2015/217047
  15. Sirey J, Banerjee S, Marino P et al. Adherence to Depression Treatment in Primary Care. JAMA Psychiatry . 2017;74(11):1129. doi:10.1001/jamapsychiatry.2017.3047
  16. Sriharsha M A. Treatment and Disease Related Factors Affecting Non-adherence among Patients on Long Term Therapy of Antidepressants. Journal of Depression and Anxiety . 2015;04(02). doi:10.4172/2167-1044.1000175
  17. Alekhya P, Sriharsha M, Priya Darsini T et al. Treatment and Disease Related Factors Affecting Non-adherence among Patients on Long Term Therapy of Antidepressants. Journal of Depression and Anxiety . 2015;04(02). doi:10.4172/2167-1044.1000175
  18. Abegaz T, Sori L, Toleha H. Self-Reported Adverse Drug Reactions, Medication Adherence, and Clinical Outcomes among Major Depressive Disorder Patients in Ethiopia: A Prospective Hospital Based Study. Psychiatry J . 2017;2017:1-8. doi:10.1155/2017/5812817
  19. Al-Jumah K, Ahmad Hassali A, El Tahir‎ K, Al Qhatani D. Factors associated with adherence to medication among depressed patients from Saudi Arabia: a cross-sectional study. Neuropsychiatr Dis Treat . 2014:2031. doi:10.2147/ndt.s71697
  20. Ho S, Jacob S, Tangiisuran B. Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study. PLoS ONE . 2017;12(6):e0179290. doi:10.1371/journal.pone.0179290
  21. Yau W, Chan M, Wing Y et al. Noncontinuous use of antidepressant in adults with major depressive disorders - a retrospective cohort study. Brain Behav . 2014;4(3):390-397. doi:10.1002/brb3.224
  22. Michel M. Adherence and Treatment Outcomes among Patients with Comorbidity of Depression and Other Mental Disorders attending Psychiatric Hospitals in Rwanda. 2014.
  23. World Health Organization (WHO). Depression and other common mental disorders: global health estimates. World Health Organization. https://www.who.int/mental_health/management/depression/prevalence_global_health_estimates/en/. Published 2017. Accessed November 13, 2019.
  24. Chong W, Aslani P, Chen T. Effectiveness of interventions to improve antidepressant medication adherence: a systematic review. Int J Clin Pract . 2011;65(9):954-975. doi:10.1111/j.1742-1241.2011.02746.x
  25. Gratacós Torras M, Pousa Tomàs E. INTERVENCIONES PARA MEJORAR LA ADHERENCIA TERAPÉUTICA EN SUJETOS CON ESQUIZOFRENIA. Papeles del Psicólogo - Psychologist Papers . 2018;39(1). doi:10.23923/pap.psicol2018.2850
  26. Ehret M, Wang M. How to increase medication adherence: What works?. Mental Health Clinician . 2013;2(8):230-232. doi:10.9740/mhc.n132973
  27. Haddad P, Brain C, Scott J. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat Outcome Meas . 2014:43. doi:10.2147/prom.s42735
  28. Nieuwlaat R, Wilczynski N, Navarro T et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews . 2014. doi:10.1002/14651858.cd000011.pub4
  29. Cameron C, Habert J, Anand L, Furtado M. Optimizing the management of depression: primary care experience. Psychiatry Res . 2014;220:S45-S57. doi:10.1016/s0165-1781(14)70005-8
  30. Mert D, Turgut N, Kelleci M, Semiz M. Perspectives on reasons of medication nonadherence in psychiatric patients. Patient Prefer Adherence . 2015:87. doi:10.2147/ppa.s75013
  31. Farooq S, Naeem F. Tackling nonadherence in psychiatric disorders: current opinion. Neuropsychiatr Dis Treat . 2014:1069. doi:10.2147/ndt.s40777
  32. Olfson M. Bringing Antidepressant Self-Discontinuation Into View. Psychiatric Services . 2015;66(5):449-449. doi:10.1176/appi.ps.660501
  33. Kleppe M. Understanding medication adherence: a self-report measure and a dual-process framework. 2016.
  34. Stein-Shvachman I. Depression Treatment Non-adherence and its Psychosocial Predictors: Differences between Young and Older Adults?. Aging Dis . 2013;4(6):329-336. doi:10.14336/ad.2013.0400329
  35. Fiaturi N, Greenblatt D. Therapeutic Drug Monitoring of Antidepressants. Antidepressants . 2018:115-133. doi:10.1007/164_2018_161
  36. Okasha A, Alkhadhari S, Al Sharqi A. Arab Treatment Guidelines for the Management of Major Depressive Disorder = دليل العلاج العربي في تدبير اضطراب الاكتئاب الجسيم. The Arab Journal of Psychiatry . 2017;28(2):97-117. doi:10.12816/0041709
  37. Párraga Martínez I, López-Torres Hidalgo J, del Campo del Campo J, Villena Ferrer A, Morena Rayo S, Escobar Rabadán F. Seguimiento de la adherencia al tratamiento antidepresivo en pacientes que inician su consumo. Atención Primaria . 2014;46(7):357-366. doi:10.1016/j.aprim.2013.11.003
  38. Tricco A, Lillie E, Zarin W et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med . 2018;169(7):467. doi:10.7326/m18-0850
  39. Munn Z, Peters M, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol . 2018;18(1). doi:10.1186/s12874-018-0611-x
  40. Hong Q, Fàbregues S, Bartlett G et al. The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Education for Information . 2018;34(4):285-291. doi:10.3233/efi-180221
  41. Scott S, Rotter T, Flynn R et al. Systematic review of the use of process evaluations in knowledge translation research. Syst Rev . 2019;8(1). doi:10.1186/s13643-019-1161-y
  42. Al-Jumah K, Ahmad Hassali A, AlQhatani S. Examining the relationship between adherence and satisfaction with antidepressant treatment. Neuropsychiatr Dis Treat . 2014:1433. doi:10.2147/ndt.s67008
  43. Aljumah K, Hassali M. Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study. BMC Psychiatry . 2015;15(1). doi:10.1186/s12888-015-0605-8
  44. Baeza-Velasco C, Olié E, Béziat S, Guillaume S, Courtet P. Determinants of suboptimal medication adherence in patients with a major depressive episode. Depress Anxiety . 2018;36(3):244-251. doi:10.1002/da.22852
  45. Bhat S, Kroehl M, Trinkley K et al. Evaluation of a Clinical Pharmacist-Led Multidisciplinary Antidepressant Telemonitoring Service in the Primary Care Setting. Popul Health Manag . 2018;21(5):366-372. doi:10.1089/pop.2017.0144
  46. Burnett-Zeigler I, Kim H, Chiang C et al. The association between race and gender, treatment attitudes, and antidepressant treatment adherence. Int J Geriatr Psychiatry . 2013;29(2):169-177. doi:10.1002/gps.3984
  47. Chatterjee S, Chatterjee A, Dogra A, Gupta S. Role of Belief about and Adherence to Medication on Symptom Severity of Life of Patients Suffering from Depressive Disorder Residing a Rural Areas of West Bengal. Eastern Journal of Psychiatry . 2017;19(2).
  48. De las Cuevas C, Peñate W, Sanz E. Risk factors for non-adherence to antidepressant treatment in patients with mood disorders. Eur J Clin Pharmacol . 2013;70(1):89-98. doi:10.1007/s00228-013-1582-9
  49. De las Cuevas C, Peñate W, Sanz E. The relationship of psychological reactance, health locus of control and sense of self-efficacy with adherence to treatment in psychiatric outpatients with depression. BMC Psychiatry . 2014;14(1). doi:10.1186/s12888-014-0324-6
  50. Isa E, Ani C, Bella-Awusah T, Omigbodun O. Effects of psycho-education plus basic cognitive behavioural therapy strategies on medication-treated adolescents with depressive disorder in Nigeria. Journal of Child & Adolescent Mental Health . 2018;30(1):11-18. doi:10.2989/17280583.2018.1424634
  51. Klein N, van Rijsbergen G, ten Doesschate M, Hollon S, Burger H, Bockting C. Beliefs about the causes of depression and recovery and their impact on adherence, dosage, and successful tapering of antidepressants. Depress Anxiety . 2017;34(3):227-235. doi:10.1002/da.22598
  52. Lu Y, Arthur D, Hu L, Cheng G, An F, Li Z. Beliefs about antidepressant medication and associated adherence among older Chinese patients with major depression: A cross-sectional survey. Int J Ment Health Nurs . 2015;25(1):71-79. doi:10.1111/inm.12181
  53. Lucca J, Ramesh M, Parthasarathi G, Ram D. Incidence and factors associated with medication nonadherence in patients with mental illness: A cross-sectional study. J Postgrad Med . 2015;61(4):251. doi:10.4103/0022-3859.166514
  54. Novick D, Montgomery W, Moneta V, Peng X, Brugnoli R, Haro J. Antidepressant medication treatment patterns in Asian patients with major depressive disorder. Patient Prefer Adherence . 2015:421. doi:10.2147/ppa.s68432
  55. Serrano M, Vives M, Mateu C et al. Therapeutic adherence in primary care depressed patients: a longitudinal study. Actas Esp Psiquiatr . 2014;42(3):91-8.
  56. Shrestha Manandhar J, Shrestha R, Basnet N et al. Study of Adherence Pattern of Antidepressants in Patients with Depression. Kathmandu University Medical Journal . 2017;15(57):3-9.
  57. Taleban R, Zamani A, Moafi M, Jiryaee N, Khadivi R. Applications of text messaging, and bibliotherapy for treatment of patients affected by depressive symptoms. Int J Prev Med . 2016;7(1):46. doi:10.4103/2008-7802.177889
  58. Vannachavee U, Seeherunwong A, Yuttatri P, Chulakadabba S. The Effect of a Drug Adherence Enhancement Program on the Drug Adherence Behaviors of Patients With Major Depressive Disorder in Thailand: A Randomized Clinical Trial. Arch Psychiatr Nurs . 2016;30(3):322-328. doi:10.1016/j.apnu.2015.12.001
  59. Bushnell G, Stürmer T, White A et al. Predicting persistence to antidepressant treatment in administrative claims data: Considering the influence of refill delays and prior persistence on other medications. J Affect Disord . 2016;196:138-147. doi:10.1016/j.jad.2016.02.012
  60. Green B, Watson M, Kaltman S et al. Knowledge and Preferences Regarding Antidepressant Medication Among Depressed Latino Patients in Primary Care. J Nerv Ment Dis . 2017;205(12):952-959. doi:10.1097/nmd.0000000000000754
  61. Grover S, Mehra A, Chakrabarti S, Avasthi A. Dropout rates and reasons for dropout from treatment among elderly patients with depression. Journal of Geriatric Mental Health . 2018;5(2):121. doi:10.4103/jgmh.jgmh_29_17
  62. Holvast F, Oude Voshaar R, Wouters H et al. Non-adherence to antidepressants among older patients with depression: a longitudinal cohort study in primary care. Fam Pract . 2018;36(1):12-20. doi:10.1093/fampra/cmy106
  63. Klang S, Ben-Amnon Y, Cohen Y, Barak Y. Community pharmacists’ support improves antidepressant adherence in the community. Int Clin Psychopharmacol . 2015;30(6):316-319. doi:10.1097/yic.0000000000000090
  64. LeBlanc A, Herrin J, Williams M et al. Shared Decision Making for Antidepressants in Primary Care. JAMA Intern Med . 2015;175(11):1761. doi:10.1001/jamainternmed.2015.5214
  65. Slabbert F, Harvey B, Brink C, Lubbe M. Prospective analysis of the medicine possession ratio of antidepressants in the private health sector of South Africa, 2006 - 2011. South African Medical Journal . 2015;105(2):139. doi:10.7196/samj.8394
  66. Zhang L, Chen Y, Yue L et al. Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People’s Republic of China. Neuropsychiatr Dis Treat . 2016:941. doi:10.2147/ndt.s97407
  67. Hammonds T, Rickert K, Goldstein C et al. Adherence to Antidepressant Medications: A Randomized Controlled Trial of Medication Reminding in College Students. Journal of American College Health . 2015;63(3):204-208. doi:10.1080/07448481.2014.975716
  68. Pradeep J, Isaacs A, Shanbag D, Selvan S, Srinivasan K. Enhanced care by community health workers in improving treatment adherence to antidepressant medication in rural women with major depression. Indian J Med Res . 2014;139(2):236-245.
  69. Srimongkon P, Aslani P, Chen T. Consumer-related factors influencing antidepressant adherence in unipolar depression: a qualitative study. Patient Prefer Adherence . 2018;Volume 12:1863-1873. doi:10.2147/ppa.s160728
  70. Vargas S, Cabassa L, Nicasio A et al. Toward a cultural adaptation of pharmacotherapy: Latino views of depression and antidepressant therapy. Transcult Psychiatry . 2015;52(2):244-273. doi:10.1177/1363461515574159
  71. Cochrane Effective Practice and Organisation of Care Review Group (EPOC). Data Collection Checklist . Epoc.cochrane.org: Cochrane; 2002. http://epoc.cochrane.org/sites/epoc.cochrane.org/files/public/uploads/datacollectionchecklist.pdf. Accessed November 14, 2019.
Table 1 . Characteristics of Selected Studies (n = 36)